Atlas Trials

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Clinical trial NCT05449717 · COMPLETED

Trial details

NCT number
NCT05449717
Sponsor
Epicentre
Status
COMPLETED
Study type
OBSERVATIONAL
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Start date
2022-05-31
Primary completion
2025-04-11
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.